... References
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
The Impact of HIV on Hispanic/Latino People in the United States — KFF
HIV Among Latinos — League of United Latin American Citizens
Putting a Number on It: The Risk From an Exposure to HIV — Stanford Medicine
Estimated HIV Risk Per Exposure — Aidsmap
...
Probabilidad de contagio de VIH en una sola exposición: todo lo que necesita saber
... References
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
The Impact of HIV on Hispanic/Latino People in the United States — KFF
HIV Among Latinos — League of United Latin American Citizens
Putting a Number on It: The Risk From an Exposure to HIV — Stanford Medicine
Estimated HIV Risk Per Exposure — Aidsmap
...
... Department of Veterans Affairs
Stigma and HIV — Centers for Disease Control and Prevention
Supporting Retention in HIV Care Through a Holistic, Patient-Centred Approach: A Qualitative Evaluation — BMC Psychology
HIV Treatment as Prevention — Centers for Disease Control and Prevention ...
... in the United States — Seminars in Arthritis and Rheumatism
HIV and Rash — HIVinfo.NIH.gov ...
... — Centers for Disease Control and Prevention
...
... — Reproducción Asistida ORG
Formas de transmisión — Amigos contra el sida
Estadísticas mundiales — HIV.gov
Post-Exposure Prophylaxis (PEP) — HIV.gov
Limits on Confidentiality — HIV.gov
...
... , and Anxiety and Depression Symptoms in Adults Living With HIV — Trends in Psychology
...
... Food and Drug Administration
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo — Drugs.com
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection — Gilead
Drug Database: Cabotegravir — Clinicalinfo.HIV.gov
VIH/sida — Mayo Clinic
Barriers to HIV Medication Adherence as a Function ...
Cómo funcionan los medicamentos inyectables para tratar y prevenir el VIH
... Food and Drug Administration
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo — Drugs.com
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection — Gilead
Drug Database: Cabotegravir — Clinicalinfo.HIV.gov
VIH/sida — Mayo Clinic
Barriers to HIV Medication Adherence as a Function ...
... Statistics — HIV.gov
Current Trends First 100,000 Cases of Acquired Immunodeficiency Syndrome — Centers for Disease Control and Prevention
Origin of HIV and AIDS — Be in the Know
The Early Spread and Epidemic Ignition of HIV-1 in Human Populations — Science
A Timeline of HIV and AIDS — HIV.gov
40 Years of HIV: Discovery From the First Cases of a Mysterious ...
¿Qué es el virus de la inmunodeficiencia humana? Qué hace y más
... Statistics — HIV.gov
Current Trends First 100,000 Cases of Acquired Immunodeficiency Syndrome — Centers for Disease Control and Prevention
Origin of HIV and AIDS — Be in the Know
The Early Spread and Epidemic Ignition of HIV-1 in Human Populations — Science
A Timeline of HIV and AIDS — HIV.gov
40 Years of HIV: Discovery From the First Cases of a Mysterious ...
... Referencias
Switch to Single-Tablet Bictegravir-Lenacapavir From a Complex HIV Regimen (Artistry-1): A Randomised, Open-Label, Phase 3 Clinical Trial — The Lancet
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy — Gilead
...
únete
Tus opciones de privacidad
